Chase AIPricingFAQs
Display currency
Loading news…

Alivexis

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Minato, Chiba, Japan Founded 2016 11-50 employees For Profit

Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
2
Patents
6

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Patents granted
6
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$9M

Company Info

Founded
2016
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
3
News articles
13
HQ
Minato, Chiba, Japan
Region
Asia-Pacific (APAC)

Signals & Scores

Heat score
Medium
Growth score
High
Trend (7d)
-0.3
Trend (30d)
-0.1
Trend (90d)
5.8

Key People at Alivexis

Representative Director, CEO and Founder
Chief Scientific Officer (CSO) and Chief Biologist
Vice President, Corporate Planning
Cofounder & President
2
professional contacts at Alivexis
Contact execs at Alivexis

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Alivexis

Loading news…

FAQs about Alivexis

People who checked this page also checked these

Browse the full Acquirezy directory.
Alivexis - Company Profile, Full Acquisitions List, Funding and Investments